Dame Catherine Elizabeth Bingham
venture capitalistBRITISHUNITED KINGDOMBorn October 1965
Current Appointments15
Quell Therapeutics Limited
activedirector · Since 28/07/2023
Alchemab Therapeutics Ltd
Activedirector · Since 26/07/2023
Enara Bio Limited
Activedirector · Since 14/06/2023
Mestag Therapeutics Ltd
Activedirector · Since 17/04/2020
Cybele Therapeutics Ltd
—director · Since 11/12/2019
Sitryx Therapeutics Limited
Activedirector · Since 01/02/2017
Pulmocide Limited
Activedirector · Since 31/10/2013
Calchan Holdings Limited
—director · Since 03/10/2011
Autifony Therapeutics Limited
Activedirector · Since 19/08/2011
Sv Health Investors Uk Limited
activedirector · Since 20/09/2004
Sv Health Investors Llp
—llp designated member · Since 02/08/2004
Sv Health Managers Llp
activellp designated member · Since 02/08/2004
Nigra Plc
—director · Since 27/07/1999
Metris Therapeutics Limited
—director · Since 30/10/1998
Schroder Ventures Life Sciences Advisers (Uk) Ltd
—director · Since 11/11/1996
Summary
Current roles15
Former roles0
Occupationventure capitalist
NationalityBRITISH
Based inUNITED KINGDOM
DOBBorn October 1965
Risk flags None detected
Financial FootprintActive cos.
Combined turnover£0
Combined net worth£37.0m
Combined profit£-12.4m
Total employees6
Based on latest filed accounts for 2 of 15 active companies.
Frequently Works With
Data sourced from Companies House public register. Financial data from filed accounts. Updated as filings are processed.